Zoetis (ZTS) EBIT Growth (3y) (2015 - 2026)
Zoetis (ZTS) EBIT Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | -59.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.36% |
| Mar 31, 2026 | 3.84% |
| Dec 31, 2025 | 4.93% |
| Sep 30, 2025 | 8.53% |
| Jun 30, 2025 | 9.19% |
| Mar 31, 2025 | 0.64% |
| Dec 31, 2024 | 8.04% |
| Sep 30, 2024 | 7.77% |
| Jun 30, 2024 | 6.51% |
| Mar 31, 2024 | 17.89% |
| Dec 31, 2023 | 10.30% |
| Sep 30, 2023 | 8.33% |
| Jun 30, 2023 | 35.88% |
| Mar 31, 2023 | 14.63% |
| Dec 31, 2022 | 127.06% |
| Sep 30, 2022 | 28.79% |
| Jun 30, 2022 | 26.32% |
| Mar 31, 2022 | 27.66% |
| Dec 31, 2021 | 96.98% |
| Sep 30, 2021 | 56.81% |